Minerva Neurosciences, Inc.
NERV
$1.73
$0.00060.04%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
4/22/2025
-
Ticker Report
4/21/2025
-
Zolmax
4/14/2025
-
Ticker Report
4/11/2025
-
Ticker Report
3/29/2025
-
Ticker Report
3/29/2025
-
Ticker Report
3/21/2025
-
Ticker Report
3/16/2025
-
Ticker Report
3/6/2025
-
TipRanks Financial Blog
2/26/2025
-
Ticker Report
2/25/2025
-
GuruFocus
2/25/2025
-
Globe Newswire
2/23/2025
-
Ticker Report
1/22/2025
-
Ticker Report
1/13/2025
-
Ticker Report
1/5/2025
-
Ticker Report
12/29/2024
-
Ticker Report
12/23/2024
-
Ticker Report
12/12/2024
-
Ticker Report
12/4/2024
-
Ticker Report
11/27/2024
-
Ticker Report
11/25/2024
-
Ticker Report
11/20/2024
-
Ticker Report
11/13/2024
-
Ticker Report
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
--
Cash from Financing (TTM)
--
Net Change in Cash (TTM)
Filings
Filing Date
Tuesday, February 25, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Beginning of May (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
617 600 7373
Address
1500 District Avenue
Burlington, MA 01803
Burlington, MA 01803
Country
Year Founded
Business Description
Sector
Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system...
more